
Hb-022 improves drug bioavailability using proprietary formulations to enhance systemic exposure. The approach combines licensed formulations technology, proprietary excipients, and AI-driven strategies to accelerate clinical development. Hb-022 partners with accredited manufacturers and pharma companies to license its technology and support faster IND, Phase I and II timelines. The company targets pharma partners and investors, highlighting capital efficiency and real-time pipeline valuation via an AI platform.

Hb-022 improves drug bioavailability using proprietary formulations to enhance systemic exposure. The approach combines licensed formulations technology, proprietary excipients, and AI-driven strategies to accelerate clinical development. Hb-022 partners with accredited manufacturers and pharma companies to license its technology and support faster IND, Phase I and II timelines. The company targets pharma partners and investors, highlighting capital efficiency and real-time pipeline valuation via an AI platform.
Hb-022 Inc. specializes in AI, clinical development and bringing new solutions to the US market.
We are currently in the process of setting up a global R&D collaboration, equivalent of clinical development for our client, a Physiotherapists Assistant app.
The app is tested on 6300 patients for shoulder, hip, knee, ankle, wrist rehab and has very positive feedback from surgeons and physiotherapists alike.
A direct to customer(wellness) version is also launched in the US and UK last week for wellness. Some individuals registered for this have requested physiotherapy help from US certified professionals.
Role Description
This is a remote engagement for anywhere in the US or Canada on an hourly basis. The app also offers opportunity to list your services or simply be part of the panel.
The Physiotherapist will virtually assist patients. S/he will assess and diagnose mobility issues, develop personalized treatment plans, provide physiotherapy sessions, and educate patients on exercises for recovery and prevention. Monitoring progress and adapting treatment plans based on response will be a part of routine responsibilities.
**Additionally, the role will involve collaboration with senior surgeons in R&D collaboratiion to enhance patient outcomes. surgeons from several states of the US, UK, Vienna, Germany, South Africa, UAE are a part of this global collaboration for reasearch oriented professionals.
Qualifications**